Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the treatment of obesity. This medication works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://hamzawipe291901.blog4youth.com/39549936/trelaglutide-exploring-a-new-option-for-chronic-diseases